[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "High US positive test rates", "description": "United States\n\nCases, 11,000,000\n\nCases in last 7 days, 1,070,850\n\nDeaths, 245,470\n\nTrends\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nOfficial US hospitalizations\n\nhttps://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html\n\nThursday, 26 November 2020\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/holidays/thanksgiving.html\n\nhttps://rt.live\n\nCalifornia\n\nhttps://www.nytimes.com/live/2020/11/16/world/covid-19-coronavirus-updates?action=click&module=Top%20Stories&pgtype=Homepage\n\nCase numbers doubled in past 10 days\n\n\nCross age, racial or ethnic groups, throughout the state\n\nFastest increase ever\n\nGovernor, pulling the emergency brake\u201d on reopening, reinstating broad restrictions\n\nMr. Newsom, emergency facility, being prepared, e.g. Imperial County\n\nResist visiting relatives over the holidays\n\nRecent rise in cases, at-home parties or family gatherings.\n\nIowa\n\nCases and hospitalizations, doubled in two weeks\n\nAnnounced mask mandate, indoors when unable to distance, starting today\n\nChicago and Philadelphia\n\nNew rules starting Friday, banning indoor gatherings, closing indoor dining\n\nIllinois\n\nNew Mexico\n\nTwo week lockdown\n\nNorth Dakota\n\nNow imposed mask mandate\n\nSouth Dakota\n\nSouth Dakota \n\nSturgis, 400,000 people\n\nhttps://coronavirus.jhu.edu/testing/individual-states/south-dakota\n\nKansas\n\nInternational review\n\nhttps://health-infobase.canada.ca/covid-19/international/\n\nCanada\n\nTrends upwards\n\nhttps://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection.html\n\nUK\n\nScotland\n\nTwo million enter level 4 (highest of five-tier system)\n\n6pm this Friday\n\nWest Dunbartonshire, East Dunbartonshire, East Renfrewshire, Glasgow City, Inverclyde, Renfrewshire, North and South Lanarkshire, West Lothian, East and West Ayrshire and Stirling.\n\nApp graphics\n\nhttps://covid.joinzoe.com/data#levels-over-time\n\nUK official data\n\nhttps://coronavirus.data.gov.uk/details/cases\n\nIndia\n\nPopulation 1.35 billion\n\nPfizer and Moderna vaccines\n\nRussia\u2019s Sputnik-V, Phase-II going to Phase-III trials in India start next\n\nAstraZeneca / Oxford, manufactured by the Serum Institute of India\n\nLast-stage trials in India, gone well and had almost been completed", "link": "https://www.youtube.com/watch?v=uGypHM5ShTM", "date_published": "2020-11-17 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Interview, vaccines and acceptance", "description": "Never enougth time on these interviews", "link": "https://www.youtube.com/watch?v=3NNp22POZ_Y", "date_published": "2020-11-17 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Second vaccine with high immunity", "description": "Moderna / NIH vaccine\n\nmRNA 1273\n\n94.5%\n\nhttps://www.businesswire.com/news/home/20201116005608/en/\n\nhttps://www.nytimes.com/2020/11/16/health/Covid-moderna-vaccine.html\n\nhttps://www.modernatx.com/modernas-work-potential-vaccine-against-covid-19\n\nPfizer /  BioNTech, 90 % \n\nhttps://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against\n\nN = 43,538 participants\n\n94 people infected so far\n\nPeople catching COVID, starting 2 weeks after second shot\n\nNo data on disease severity\n\nFood and Drug Administration, 50 % to be approved\n\nModeran trial\n\nDouble blind\n\n4 weeks between shots\n\n25,650 participants have received two shots\n\n37 % from communities of color\n\n42 % from populations high risk, (over 65 or diabetes, obesity, heart disease)\n\n95 people contracted the virus, 11 of these had severe disuses\n\nNo children\n\nAdolescents soon, moving on to children\n\nModeran vaccination group\n\n5 people contracted coronavirus\n\nModerna control group (salty water)\n\n90 people contracted coronavirus\n\n11 of whom had severe disease\n\nDifferences between groups was highly significant\n\nResults analyzed by independent data safety monitoring board (appointed by the National Institutes of Health)\n\nResults were so strong; company felt an ethical obligation to offer the vaccine to the placebo group as soon as possible\n\nDr. Anthony Fauci\n\nI had been saying I would be satisfied with a 75 % effective vaccine\n\nAspirationally, you would like to see 90, 95 %, but I wasn\u2019t expecting it. \n\nI thought we\u2019d be good, but 94.5 percent is very impressive.\n\nBoth vaccines\n\nMore cases have acetated results\n\nStudies continuing\n\nTarget the spike protein\n\nRequire 2 shots\n\nNot found serious side effects\n\nSore arms, fatigue, fever and joint and muscle aches that last for a day or two\n\nVaccine storage and transport\n\nDifferent formulations of lipid \n\nModerna\n\nMinus 20\u2019C (- 4 Fahrenheit) \n\nWill last 30 days in the refrigerator\n\nOrdinary freezer, six months\n\n12 hours at room temperature\n\nPfizer\n\nMinus 70\u2019 C (- 94 Fahrenheit)\n\nRoll out\n\nBoth about to apply for emergency FDA authorization\n\nRoll out, Moderna\n\n20 million doses ready by end of 2020\n\n500 million to one billion doses in 2021\n\nManufacture in US, Switzerland, Spain\n\nTwo-month follow-up safety data, as (required by FDA), second half of November\n\ni.e. watch trial subjects for two months after they receive a final dose for any side effects that may crop up\n\nThen, will file for an emergency use authorization\n\nGovernment authorising agencies, Britain, Canada, Europe\n\nUS, 100 million with options on 400 million more\n\nEU, 80 million doses\n\nJapan, 50 million doses\n\nCanada, 20 million\n\nSwitzerland, 4.5 million\n\nUK orders 5 million doses for spring\n\nQatar and Israel\n\nIn talks with the WHO, COVAX, distribution and a tiered pricing proposal\n\nRoll out, Pfizer\n\n50 million doses by end of 2020\n\nUS, 100 \u2013 500 million doses\n\nEU, 200 million doses\n\nUK, 40 million doses\n\nAZ / Oxford\n\nEU, 400 million doses\n\nUK, 100 million\n\nVaccines alliance for poorer countries, 300 million\n\n\n\nCosts, Sanofi and GSK\n\nBoth expected to cost about \u00a38 a dose\n\nAZ / Oxford\n\n\u00a3 3 per dose\n\n\nCosts, Moderna\n\nUS, government will buy, free to the public\n\nUS warp speed, already put in 2.5 billion, $24.80 a shot\n\nBoth companies making a profit\n\nModerna, overseas charge, $32 to $37 per dose\n\nProbably about \u00a342 per course\n\nCosts, Pfizer\n\nOperation Warp Speed has promised Pfizer $1.95 billion to provide 100 million doses\n\n$19.50 per dose.\n\n\nUnclear points\n\nAge distribution of infections\n\nPerson to person reduction\n\nHow long immunity will last", "link": "https://www.youtube.com/watch?v=Fiq5ymktg6w", "date_published": "2020-11-16 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]